genOway designs and develops accurate in vivo and in vitro preclinical models for target validation, compound efficacy assessment and safety studies. The company holds exclusive intellectual property on key technologies for model creation and provides access to more than 10,000 knockout and reporter mouse models of target validation.
14 of the Top 20 Pharmas use our services and benefit from our strong scientific input in preclinical models conception, development and management of complex projects. Combining our unrivaled scientific expertise with a robust production platform, the focus of genOway is to provide pharmaceutical companies highly relevant and physiological models within the shortest timelines, to speed up preclinical research projects and enhance clinical trial success rates. Models are provided with all the required freedom to operate.
